Conference Coverage
Conference Coverage
Randomized Trial Confirms Prognostic Value of Neurofilament Light Chains in MS
ASCLEPIOS substudies find high sNfL levels at 3 and 12 months predictive of future CNS activity in patients with MS.
Conference Coverage
Barriers to Remyelinating Drugs in MS Are Falling as Science Advances
“Once we understand the biology, we can turn barriers into opportunities.”
Conference Coverage
Is Migraine a Forerunner of Multiple Sclerosis?
“The inflammatory setting of the first MS relapse might be actually triggering the migraine.”
Conference Coverage
Paramagnetic Rim Lesions Gain Traction as Prognostic Biomarker in MS
Paramagnetic rim lesions (PRLs) predict cognitive impairment among other signs of aggressive multiple sclerosis.
Conference Coverage
Adding Antithrombotic to tPA Does Not Improve Stroke Outcome
The Multi-Arm Optimization of Stroke Thrombolysis (MOST) trial was stopped early due to futility.
Conference Coverage
Expanded Window of Stroke Thrombectomy With Simpler Imaging
Conference Coverage
Hypertension Before Age 35 Tied to Triple Stroke Risk in Midlife
“For Black women specifically, there is a concern, as we know this group has higher rates of raised blood pressure and stroke overall.”
Conference Coverage
With Proper Training, AI Can Be a Useful Tool in Epilepsy Management
“Artificial intelligence will not replace clinicians, but clinicians assisted by artificial intelligence will replace clinicians without...
Conference Coverage
Genetic Testing Is Recommended for Adult Patients With Epilepsy
Conference Coverage
Alzheimer’s and Epilepsy: Can Shared Molecular Mechanisms Reveal New Opportunities for Epilepsy?
The prognosis looks comparatively worse for patients who have Alzheimer’s disease and comorbid epilepsy than for patients who have only epilepsy...
Conference Coverage
Despite Few CNS Gene Therapies for Epilepsy, New Research Offers Hope